Researchers & UT Community
Proof of Concept Awards
TEXAS PROOF OF CONCEPT AWARDS
These awards provide competitive funding for UT faculty members or permanent researchers with a principal investigator (PI) status to accelerate the tech commercialization process.
Texas Proof of Concept Awards
- Maximum value of $25,000
- No matching requirement
Texas+ Proof of Concept Awards
Requires the applicant to secure $125,000 in matching funds from an industry partner
Maximum value of $125,000
HOW TO APPLY
Applicants from any UT college, school, or unit may apply for one or both awards in any order; however, if a UT researcher wins both a Texas and Texas+ Proof of Concept award for a specific innovation, their total funding is limited to $125,000. In addition, applicants can receive a maximum of two Proof of Concept awards per year.
Email pocawards@austin.utexas.edu with questions.
Application cycles occur during the Fall and Spring semesters.
Key Dates:
Applications Open: Monday, September 7, 2026
Application Deadline: Monday, October 12, 2026
Application Decisions: Friday, December 04, 2026
Award Ceremony: Friday, December 11, 2026
Deadlines are by 5:00 p.m. (Central) on the day indicated
Explore guidelines and view a sample application here.
Frequently Asked Questions
There are a variety of information sessions across campus. If you would like the Innovation Program Manager to come present to your college or faculty group specifically please contact them directly.
If you have questions that are not addressed in the Request for Applications & Guidelines, please contact the Innovation Program Manager.
Exceptions will be extremely rare and must be proposed by email to the Innovation Program Manager at least one week before the respective deadline. Exception proposals must provide a clear and convincing rationale.
Connect with the Intellectual Property Development team to discuss how this program can help protect and promote your discoveries. Contact us.
Please see the Application Review Criteria and let the Innovation Program Manager know if you have any questions.
- There are currently no required pre-requisite trainings for POC Award applicants; however, participation in the NSF I-Corps or similar programs is recommended.
- While POC Awards are focused on derisking the innovation or technology itself by pursuing commercially relevant milestones with clear, data-driven, go- no-go decisions, it is also important to understand customer needs and validate the market potential of the innovation or technology so that the team can work towards a commercially viable solution.
- Although prior I-Corps (or similar) participation is not mandatory, if there is not a clear
and validated market opportunity, the review committee may require completion of such
training as a condition for receiving a POC Award or before allowing a re-submission. - Please note that if you are a recipient of a Cockrell Innovation Grant, you must commit to completing an NSF I-Corps Regional or National program before or during the proposed period of performance
You will be notified at your UT email by the Innovation Program Manager with any decisions or questions concerning your POC application.
Applicants may resubmit once per technology (UT Tech ID) if they thoroughly address all reviewer feedback received.
In certain circumstances, Texas POC Awards can be made for discoveries that are already licensed to a startup on a case-by-case basis, dependent on the proposed work and status of the licensing partner. Discoveries licensed to established companies (non-startups) are not eligible for POC Awards. Applications involving licensed discoveries must be discussed with the Innovation Program Manager at least two weeks before the respective application deadline.
- Faculty salary or non-UT employee salary
- Student tuition or fees
- Travel expenditures
- Basic, fundamental, or exploratory research without clear commercial relevance
- Business development, planning, customer discovery, or market validation efforts (other
resources, such as I-Corps, exist to help with these efforts) - Capital equipment (equipment costing $5,000 or more)
- General facilities and administration (overhead/indirect) costs. POC funding is internal,
so overhead/indirect costs do not need to be budgeted - Publication costs
- Intellectual property application, prosecution, translation, or freedom to operate costs.
We encourage applicants to engage with the Intellectual Property Development team
to discuss these items - Please note that all uses of proceeds must enhance the ability for UT to further develop
and license the related discoveries
In addition to the examples of allowable costs and projects in the earlier Scope section for POC Awards, Cockrell Innovation Grants can also be used for the following items:
- Make, test or demo prototype (and associated travel, if necessary for project success)
- Validating market and/or pricing models
- Graduate student tuition for active students working on the funded project
- Postdoctoral or graduate student salary for those actively working on the funded project
No, all applications will be assessed in the same manner and with the same review criteria, with funding decisions made irrespective of the PI’s college or school affiliation.
If anything, we expect that Cockrell’s support of some projects with Cockrell Innovation Grants will free up funding for non-Cockrell applications. We encourage PIs from all colleges and schools to apply.
The POC program will not accept in-kind, non-cash, contributions for matching purposes. In general, Federal funds are not accepted for matching purposes.
Contact us with any questions regarding the Discovery to Impact Proof of Concept Awards program. If you would like to discuss any specific eligibility questions or details about your potential POC project, please include days and times that would work for a Zoom call in your email correspondence.
Spring 2026 Awardees
PAST Award Recipients
-
Jean Anne Incorvia Integrate and Fire Magnetic Neurons for Efficient AI Data Processing
Synopsis:
This project advances a new class of spintronic, CMOS‑compatible artificial neurons that integrate biologically inspired “integrate‑and‑fire” behavior into a single high‑endurance nanodevice, enabling far more energy‑efficient AI computation. The work will scale laboratory‑validated magnetic neuron prototypes to industry‑relevant fabrication platforms, de‑risking manufacturing and integration with existing semiconductor processes. Successful demonstration positions the technology for future licensing or startup formation to address the rapidly growing neuromorphic computing market.
-
Jessica Ciarla Sustainable Trimmings for the Fashion Industry
Synopsis:
Roughly 20% of the nearly 400 million tons of plastic produced globally using fossil fuels is for textile fibers and only about 15% of it is recycled. UT inventors are developing non-plastic sustainable trimmings and embellishments, such as sequins, for the fashion industry using compostable polylactic acid.
-
Jonathan Chen Fabric Strain Sensor Device for Pharyngeal Rehabilitation
Synopsis:
Swallowing dysfunction affects roughly 500,000 children and nine million adults in the US, potentially resulting in life-threatening choking and pneumonia. Clinical swallowing evaluations and technology only capture a snapshot of behavior, resulting in low validity of current testing, especially for children. UT scientists are seeking to provide a noninvasive and unobtrusive testing procedure for patients using novel sensing fabric that is able to be worn and washed for daily living.
-
Jorge Prozzi Efficient Pavement Friction Prediction Using AI Models
Synopsis:
Monitoring the friction levels of roadways, runways, and other pavement surfaces is critical for safety, but current methods are too costly, inefficient, and often use a lot of water. UT scientists have developed a robust and fast system that doesn’t rely on water, using lasers and artificial intelligence to collect three-dimensional data of pavement texture and corresponding friction predictions to increase highway satefy.
-
Juan Guan A Novel Treatment for TKI-resistant Non-Small Cell Lung Cancer
Synopsis:
A new therapeutic strategy is being advanced to address tyrosine kinase inhibitor–resistant non‑small cell lung cancer by targeting a newly identified cancer mechanism involving biomolecular condensates formed by the EML4‑ALK fusion protein. The approach uses mRNA lipid nanoparticles to deliver short peptides that selectively disrupt these condensates, shutting down cancer signaling while sparing normal cells and reducing the likelihood of resistance. Proof of concept funding supports formulation optimization and cell‑based validation to position this platform for future animal studies, licensing, and potential startup formation.
-
Karol Lang Modular multi-modal medical imaging
Synopsis:
This award supports development of a low‑cost, modular, multimodal medical imaging system that combines in‑beam PET and prompt gamma imaging to improve proton therapy guidance and expand research applications. The technology enables high‑resolution, adaptable imaging during and after irradiation, addressing a critical gap in real‑time proton range verification while remaining significantly more affordable than existing clinical scanners. Proof‑of‑concept funding advances prototype development and in‑beam validation, positioning the platform for preclinical adoption and future clinical translation.
-
Ken Keiler New Antibiotics to Treat Emerging Lung Pathogens
Synopsis:
Researchers are developing a new class of small‑molecule antibiotics that target an essential bacterial process to treat non‑tuberculous mycobacterial (NTM) lung infections, which are rising rapidly and lack effective FDA‑approved therapies. The team has identified novel oxadiazole compounds that kill the most common and drug‑resistant NTM species without the iron‑binding limitations that hinder prior candidates, positioning them for oral administration and improved patient outcomes. Proof‑of‑concept funding supports lead optimization and early pharmacology studies to advance these candidates toward animal efficacy testing and future clinical development.
-
Lisa Griffin Vibrating Insoles for Diabetic Peripheral Neuropathy
Synopsis:
Currently, 38% of adults in the United States have diabetes and half of them have diabetic peripheral neuropathy which reduces sensory feedback from the foot, disrupting balance and often causing falls. Drugs do not address non-pain symptoms of this condition and there are currently no devices that can treat this type of neuropathy. A team led by Dr. Lisa Griffin is developing insoles that provide unnoticeable vibrations to increase blood flow and sensation, ideally providing a therapeutic effect for patients.
-
Manish Kumar Advanced Water Filtration Material
Synopsis:
Water is a critical resource for many different industries and it must be treated to specific standards, often involving chemicals or energy-intensive operations. Innovators at UT have developed sustainable, low-cost plant-based filters that remove high amounts of viruses, bacteria, and oil from water.
-
Maria Croyle NOVEL Approach to Oral Administration of Biological drugs for Wildlife (and Humans)
Synopsis:
This project advances a novel hydrogel‑based oral delivery platform that enables reliable administration of vaccines and biological drugs through chewing‑activated release, overcoming major limitations of existing wildlife bait technologies. The approach demonstrates improved stability of live and other sensitive biologics at ambient conditions while ensuring effective dosing through adhesion and controlled release in the oral cavity. Proof‑of‑concept funding supports validation of the platform’s versatility and performance, positioning it for application in wildlife disease prevention with future potential translation to human health.
-
Marissa (Nichole) Rylander Rapid Thermal Control of Liquids (RealCooL) Platform Technology
Synopsis:
Human milk provides critical nutrients for babies, but caregivers are often frustrated when trying to store and warm the milk. Additionally, the nonuniformity and overheating/overcooling of milk by current methods can degrade the milk and cause burns. UT engineers have invented a device that can precisely pasteurize, thaw, refrigerate, and rewarm human milk with a single device. The technology can also be used for wine and other beverages.
-
Marissa Burgermaster Enabling Doctors to Provide Effective Nutrition Care
Synopsis:
Nutri© is a clinical decision‑support platform that enables primary care providers to deliver personalized, evidence‑based nutrition care during routine medical visits, addressing a major gap in diabetes and cardiometabolic care. By integrating patient‑reported diet data with a user‑tested, behavior‑science–driven workflow, the tool supports shared goal setting, documentation, and follow‑up without requiring dietitian involvement. Proof‑of‑concept funding advanced development of commercially viable patient and clinic administrator features to support workflow integration, reimbursement, and broader adoption in real‑world clinical settings.
Discovery to Impact partners with researchers, inventors, investors, and entrepreneurs at every step of their journey in relentless pursuit of changing the world.








